Bod links with Uni of Sydney’s Lambert
MEDICINAL cannabis and health products company Bod has announced it has entered a research collaboration with the University of Sydney Lambert Initiative for the development of a compound marker required in the Phase I clinical trial of Bod’s sublingual cannabis wafer.
The Lambert Initiative was formed in 2015 following a $33.7m donation from the Lambert family to the university for research into therapeutic uses of medicinal cannabis.
The grant will cover around 50% of the total project costs.
Bod says the Phase I Clinical trial continues with initial results expected in Nov 2018.